Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 6/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.55 |
| ▸ | IDO1 | P14902 | 7/20 | 0.48 |
| ▸ | TDO2 | P48775 | 3/20 | 0.48 |
| ▸ | GSTP1 | P09211 | 7/20 | 0.41 |
| ▸ | GSTM2 | P28161 | 7/20 | 0.41 |
| ▸ | MYC | P01106 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31054063 | 0.86 | MEN1 (0.53) | MEN1KMT2AIDO1TDO2GSTP1 | |
| SCHEMBL31590065 | 0.79 | IDO1 (0.43) | MEN1KMT2AIDO1TDO2GSTP1 | |
| SCHEMBL31054034 | 0.78 | MEN1 (0.46) | MEN1KMT2AIDO1TDO2GSTP1 | |
| SCHEMBL31589421 | 0.74 | IDO1 (0.48) | MEN1KMT2AIDO1TDO2GSTP1 | |
| SCHEMBL31053997 | 0.73 | IDO1 (0.45) | MEN1KMT2AIDO1TDO2GSTP1 | |
| SCHEMBL31589993 | 0.73 | MEN1 (0.43) | MEN1KMT2AIDO1TDO2GSTP1 | |
| SCHEMBL30521247 | 0.72 | IDO1 (0.49) | MEN1KMT2AIDO1TDO2GSTP1 | |
| SCHEMBL31589556 | 0.72 | IDO1 (0.42) | MEN1KMT2AIDO1TDO2GSTP1 | |
| SCHEMBL6833676 | 0.71 | MEN1 (1.00) | MEN1KMT2AIDO1GSTP1GSTM2 | |
| SCHEMBL31589214 | 0.71 | MEN1 (0.41) | MEN1KMT2AIDO1TDO2GSTP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118574822-A | Novel PROTAC compounds | 甘李药业股份有限公司 | 2024-08-30 | — | — | CN | disclosed |